AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Archive - News
Corporate Rebranding Announcement
AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience
AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress
AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.
AgNovos Healthcare to Participate in German Society for Geriatric Traumatology Congress (Alterstraumatologie)
2022 ESCEO-AgNovos Young Investigator Award
It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at World Congress on Osteoporosis in March 2022.
AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.